low cd 4 whit haart
Jun 4, 2010
i am 35 y o , i am taking sustiva +abacavir+lamivudine from 2 years cd 4 grow up max 370 then low under 300 then 320 ,then 270, there s not a big grow up, whit haart no viralod, doctor want change efavirerenz whit reyataz...to see if cd 4 grow up better. i begin terapy whit 250, no illness, what do you advice...what can i do
Response from Dr. McGowan
Thanks for your post.
The medication is working to suppress the HIV, which is its main function. The increase of the CD4 count has less to do with the medicine and more to do with your body. Be sure that you are eating well and get your vitamins. Be sure that your doctor has looked for any infections or conditions that could cause inflammation in your body that might be keeping your CD4 from increasing. Changing meds may or may not help. Protease inhibitors (of which Reyataz is an example) have shown better CD4 increases than other combinations, but this has not been linked with better health. Since you have not been sick the switch may not add anything. You should discuss your concerns with your doctor and decide together what would be best.
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Hpv After Breast Sucking Sign Of HIV AIDS
- Itchy Skin After Blowjob Sign Of HIV AIDS
- Painful Red Spots After Open Mouth Kissing Worried I Have HIV
- Does Doxycycline Cure Chlamydia In One Day?
- Can You Think You Have Mono And Really Have Hiv?
- Does Having Diarrhea Affect Absorption Of HIV Meds?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.